Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Genetic Engineering News: Breaking Genetic Engineering News, Comments and Articles.

20:35 EDT 28th July 2014 | BioPortfolio

Genetic Engineering NewsRSS

Read the latest Genetic Engineering News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Genetic Engineering.

Search or Follow Our Genetic Engineering News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Genetic Engineering News.

Showing "genetic engineering genetics" News Articles 1 to 25 of 7,700+

Monday 28th July 2014

Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells

Discovery Accepted into NCI Drug Development Program for Clinical Trials Philadelphia, PA (PRWEB) July 28, 2014 An estimated 68,000 women and men in the U.S. die each year from metastatic breast and prostate cancers – an aggressive form of the disease that occurs when the cancer has spread to other parts of the body, such as the lungs, liver, bones, or brain. Now researchers at Drexel Universit...

BioFire Awarded Purchasing Agreement with HealthTrust for FilmArray™ System

BioFire Diagnostics, LLC, bioMérieux’s molecular biology affiliate, today announced that it has recently signed a new purchasing agreement with HealthTrust to provide multi-target molecular diagnostics tests for its nearly 1,400 member facilities. Under the agreement, HealthTrust will provide its facilities with the opportunity to purchase BioF...

Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

Transparency Market Research has announced the addition of the "Regenerative Medicine Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019" report to their offering. Browse the full report: http://www.transparencymarketresearch.com/regenerative-medicines-market.html. (PRWEB) July 28, 2014 According to a new market research report published by Transparen...

Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting

Proove Biosciences will present evidence-based research on how genetic testing and their proprietary services can improve chronic pain treatment. Irvine, CA and Annapolis Junction, MD (PRWEB) July 28, 2014 Proove Biosciences, the commercial and research leader in personalized medicine, will be exhibiting data and research conducted through their latest proprietary testing services at this year’...

Six New Genetic Risk Factors for Parkinson’s Found

Using data from over 18,000 patients, scientists have identified more than two dozen genetic risk factors involved in Parkinson’s disease, including six that had not been previously reported.

Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Transparency Market Research has published a new report titled "Global E-Clinical Solution Software Market: Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/e-clinical-solution-software-market.html. Albany, New York (PRWEB) July 28, 2014 According to a new market report publish...

Technology translation engine launches “organs-on-chips” company

The Wyss Institute for Biologically Inspired Engineering at Harvard Univ.Read more about Technology translati

Surgical Theater Names Former Given Imaging Ltd. and Philips Healthcare Executives to Business Advisory Board

CLEVELAND, July 28, 2014 /PRNewswire/ -- Surgical Theater, LLC announced today the addition of two new members to its Business Advisory Board. New members include Ori J. Braun, former Senior Vice President for Business Development and New Technologies for Given Imaging Ltd., and James (Jim) Fulton, former Senior Vice President and General Manager of Philips Healthcare's Computer Tomography bu...

Scientists find genetic mutations linked to salivary gland tumors

Research conducted at the Florida campus of The Scripps Research Institute (TSRI) has discovered links between a set of genes known to promote tumor growth and mucoepidermoid carcinoma, an oral cancer that affects the salivary glands. The discovery c...

Redbiotec and GE Healthcare Collaborate to Advance CMV Vaccine Development and Manufacturing

Companies combine expertise to produce cytomegalovirus vaccine candidates Redbiotec, a biopharmaceutical company specializing in vaccine development, has successfully applied its unique expertise and innovative technology platform to complete a collaborative program with global multinational, GE Healthcare Life Sciences. Using GE Healthcare's si...

Nalgene Encourages America to Drink Up!

New Bottle Design and Logo Benefits the Partnership for a Healthier America’s Drink Up Initiative Nalgene® has teamed with the Partnership for a Healthier America (PHA) in its Drink Up initiative, an effort that encourages Americans to drink more water, more often. Nalgene has designed an exclusive Drink Up reusable water bottle to help Americans dr...

IMBRUVICA® (ibrutinib) Receives Regular Approval by U.S. FDA in Chronic Lymphocytic Leukemia (CLL) and CLL patients with del 17p

HORSHAM, Pa., July 28, 2014 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for IMBRUVICA® (ibrutinib) capsules for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.[1] The FDA also approved IMBRUVICA for CLL patients with del 17p,[1] a genetic mutation that occu...

PLXNA4 gene may increase risk of developing Alzheimer's disease

Researchers from Boston University School of Medicine report variants in a new gene, PLXNA4, which may increase the risk of developing Alzheimer's disease (AD). The discovery of this novel genetic association may lead to new drug treatment options th...

MCIC Vermont Patient Safety Organization Selects ECRI Institute PSO to Analyze Adverse Events, Improve Patient Safety

PLYMOUTH MEETING, Pa., July 28, 2014 /PRNewswire-USNewswire/ -- ECRI Institute Patient Safety Organization (PSO) has been selected to provide patient safety collection, analysis, and reporting services to MCIC Vermont, Inc. PSO, a component entity of MCIC Vermont (A Reciprocal Risk Retention Group) (MCIC). MCIC is a specialty insurance company which provides medical professional and general l...

Cytonet’s Liver Cell Therapy May Be Effective in Stabilizing Children with Severe Urea Cycle Disorders Awaiting Liver Transplant

New Data Presented at the 2014 World Transplant Congress Cytonet announced today that new research on its investigational liver cell therapy (LCT) was presented on July 27, 2014 at the

CN Bio Innovations Marks World Hepatitis Day by Signing Research Agreement with Imperial College London

Collaboration will develop and further validate CN Bio’s in vitro model of Hepatitis B liver infection CN Bio Innovations Ltd (CN Bio), an expert in developing leading edge human biomimetic platforms to test and develop therapeutics for serious diseases, announced today that it has signed a research agreement with Imperial College London to advance t...

Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc

New Market Research Reports Title “Global Biotechnology Market Analysis Size And Segment Forecasts To 2020” Has Been Added to GrandViewReseach.com Report Database. View Full Report - http://www.grandviewresearch.com/industry-analysis/biotechnology-market. San Francisco, California (PRWEB) July 28, 2014 The global market for biotechnology is expected to reach USD 604.40 billion by 2020, accord...

Epizyme, Inc. to Report Second Quarter Financial Results and Provide Corporate Update on August 13, 2014

-- Company to present pre-clinical data and early clinical observations from Phase 1 study of EPZ-6438 (E7438) at ASH Lymphoma meeting on August 12, 2014 -- Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it w...

Advanced Generation Folate Therapy-EnLyte-Patented To Treat High Homocysteine, a Condition Associated with PTSD, Announces JayMac Pharmaceuticals, LLC

PTSD has been shown to be associated with high homocysteine, a condition treated with EnLyte, a new, natural folate therapy. (PRWEB) July 28, 2014 PTSD (Post Traumatic Stress Disorder) among military men and women is prevalent, with over 10,000 new cases diagnosed each year, some requiring hospitalization. A link between PTSD and high homocysteine – an amino acid – has been validated in many...

Appistry Names Industry Experts from the National Center for Genome Resources and Mercy Children's, Kansas City, to Judge Pipeline Challenge Competition

Appistry, Inc., a leading provider of tools, software, and services that bring the power of genomics to next-generation medicine, announced today its judging panel for the inaugural Appistry Pipeline Challenge. The Pipeline Challenge, which runs from July 8 - August 15, will reward one winning bioinformatics team with a $70,000 prize package for developing and executing next-generation sequencing...

New Genetic Risk Factors for Parkinson's Identified

A large-scale meta-analysis of genome data unearths 6 new risk loci for PD. Medscape Medical News

Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE

LEHIGH VALLEY, Pa., July 28, 2014 /PRNewswire/ -- Air Products (NYSE: APD) understands that a reliable, uninterrupted supply of medical oxygen is vital to any healthcare facility. This understanding has driven the company to technical innovations that not only improve the efficiency of its oxygen supply systems, but also optimize gas use. Air Products will highlight these systems—includ...

Imperial College London - Product Pipeline Analysis, 2014 Update

Recently added to the BioPortfolio report store, Imperial College London - Product Pipeline Analysis, 2014 Update is a new report from GlobalData published on 2014-07-14. This 65-page report is available in PDF from $750. Summary Imperial College London (Imperial) is an educational institution. It offers undergraduate and postgraduate courses in science and technology, agriculture, business, the...

Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update

Recently added to the BioPortfolio report store, Transgenomic, Inc. (TBIO) - Product Pipeline Analysis, 2014 Update is a new report from GlobalData published on 2014-07-14. This 34-page report is available in PDF from $750. Summary Transgenomic, Inc. (Transgenomic) is a biotechnology company. The company offers medicine in cardiology, oncology, and inherited diseases through its molecular techno...

Eidgenossische Technische Hochschule Zurich - Product Pipeline Analysis, 2014 Update

Recently added to the BioPortfolio report store, Eidgenossische Technische Hochschule Zurich - Product Pipeline Analysis, 2014 Update is a new report from GlobalData published on 2014-07-14. This 21-page report is available in PDF from $750. Summary Eidgenossische Technische Hochschule Zurich (ETH Zurich) is an educational research university. It is an international university for technology and...


Search BioPortfolio:
Advertisement
Advertisement

News Quicklinks